跳转至内容
Merck
所有图片(1)

文件

EHU060091

Sigma-Aldrich

MISSION® esiRNA

targeting human SYVN1

登录查看公司和协议定价
所有图片(1)

About This Item

分類程式碼代碼:
41105324
NACRES:
NA.51

描述

Powered by Eupheria Biotech

產品線

MISSION®

形狀

lyophilized powder

esiRNA cDNA 標靶序列

GCTGGAGGCAAGCTATGAACTTGCTCGCTGGCCCACCCCTAAGACTGGTACCCATTTCCTTTTCTTACCCTGATCTCCCCAGAAGCCTCTTGTGGTGGTGGCTGTGCCCCCTATGCCCTGTGGCATTTCTGCGTCTTACTGGCAACCACACAACTCAGGGAAAGGAATGCCTGGGAGTGGGGGTGCAGGCGGGCAGCACTGAGGGACCCTGCCCCGCCCCTCCCCCCAGGCCCCTTTCCTCTGCAGCTTCTCAAGTGAGACTGACCTGTCTCACCCAGCAGCCACTGCCCAGCCGCACTCCAGGCAAGGGCCAGTGCGCCTGCTCCTGACCACTGCAATCCCAGCGCCCAAGGAAGGCCACTTCTCAACTGGCAGAACTTCTGAAGTTTAGAATTGGAATTACTTCCTTACTAGTGTCTTTTGGCTTAAATTTTGTCTTTTGAAGTTGAATGCTTAATCCCGGGAAAGAGGAACAGGAGTGCCAGA

Ensembl | 人類登錄號

ENSG00000162298

NCBI登錄號

NM_172230

運輸包裝

ambient

儲存溫度

−20°C

基因資訊

human ... SYVN1(84447) , SYVN1(84447)

一般說明

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

法律資訊

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

10 - Combustible liquids

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Yosuke Osaki et al.
Biochemical and biophysical research communications, 514(1), 217-223 (2019-04-29)
Mucopolysaccharidosis type II (MPS II) is one of the most common mucopolysaccharidoses, which is caused by mutation of the gene encoding iduronate 2-sulfatase (IDS). The loss of function of IDS leads to the accumulation of heparan sulfate and dermatan sulfate
Marioara Chiritoiu et al.
International journal of molecular sciences, 21(10) (2020-05-20)
Endoplasmic reticulum (ER)-associated degradation (ERAD) is the main mechanism of targeting ER proteins for degradation to maintain homeostasis, and perturbations of ERAD lead to pathological conditions. ER-degradation enhancing α-mannosidase-like (EDEM1) was proposed to extract terminally misfolded proteins from the calnexin

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门